WSHA is collaborating with key partners to increase opioid stewardship in Washington and Oregon, with a goal of improving opioid prescribing practices, preventing future opioid dependence, reducing overdoses and increasing access to treatment. This will be accomplished through provider education, community partnerships, leveraging prescriber data to drive change and policy recommendations.
Key activities underway include:
- Enrolling providers to receive opioid prescribing feedback reports, in partnership with the Washington State Medical Association. By leveraging the Prescription Drug Monitoring Program database to generate peer benchmarks on acute, chronic, high dose and co-prescribing of sedatives, compliance with CDC and Bree Collaborative guidelines is increasing.
- WSHA is supportive of Emergency Departments prescribing and dispensing naloxone (opioid overdose rescue medication). Several hospitals are dispensing take-home naloxone kits.
- Aligned with the American College of Emergency Physicians, WSHA is assisting Emergency Departments in WA State to initiate medication-assisted therapy (MAT) for patients with opioid use disorder. Protocols are being adopted to include screening for opioid use disorder, initiation of MAT, and rapid referral to ongoing community-based treatment.
- While several commercial pharmacies participate in drug takeback efforts, WSHA encourages hospitals to establish onsite takeback locations. Toolkits and resources are available upon request.
- Washington: Opioid-Involved Deaths and Related Harms | National Institute on Drug Abuse (NIDA)
- Opioid Stewardship Collaborative | AHA
- HIIN-opioid-guide-0520.pdf (aha.org)
- EHRA CDC Opioid Guideline Implementation Guide for EHRs (chimecentral.org)
- CDC National Opioid Prescribing best practice guidelines
- Bree Collaborative Opioid Prescribing
- ACEP–MAT in the ED
- ACEP // Medication Assisted Treatment (MAT) FAQs
- Become a Buprenorphine Waivered Practitioner | SAMHSA